Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan

International Journal of Cancer

Volumn 131, Issue 8, 2012, Pages 1921-1929

  Lacey Jr , James V ^a,g   Chia, Victoria M ^a,h   Rush, Brenda B ^b   Carreon, Danny J ^a   Richesson, Douglas A ^a,i   Ioffe, Olga B ^c   Ronnett, Brigitte M ^d   Chatterjee, Nilanjan ^e   Langholz, Bryan ^f   Sherman, Mark E ^a   Glass, Andrew G ^b  

^a Division of Cancer Epidemiology and Genetics   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h AMGEN INC   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

atypical hyperplasia; epidemiology; gynecologic oncology; joinpoint regression; uterine carcinoma

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HUMAN; HYSTERECTOMY; KAISER PERMANENTE NORTHWEST HEALTH PLAN; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADULT; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; INCIDENCE; PREPAID HEALTH PLANS; PROGNOSIS; TIME FACTORS;

EID: 84865347745     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27457     Document Type: Article

References (42)

1. Weiss NS, Szekely DR, Austin DF,. Increasing incidence of endometrial cancer in the United States. N Engl J Med 1976; 294: 1259-62.
2. Ziel HK, Finkle WD,. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293: 1167-70.
3. Smith DC, Prentice R, Thompson DJ, Herrmann WL,. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975; 293: 1164-7.
4. Jick H, Walker AM, Rothman KJ,. The epidemic of endometrial cancer: a commentary. Am J Public Health 1980; 70: 264-7.
5. Austin DF, Roe KM,. The decreasing incidence of endometrial cancer: public health implications. Am J Public Health 1982; 72: 65-8. (Pubitemid 12244615)
6. Jemal A, Siegel R, Xu J, Ward E,. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
7. Flegal KM, Carroll MD, Ogden CL, Johnson CL,. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288: 1723-7.
8. Calle EE, Kaaks R,. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-91. (Pubitemid 39025053)
9. Lindemann K, Eskild A, Vatten LJ, Bray F,. Endometrial cancer incidence trends in Norway during 1953-2007 and predictions for 2008-2027. Int J Cancer 2010;127:2661-8.
10. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariottto A, Eisner MP, et al. Cancer statistics review, 1975-2007, edn. Bethesda, MD: National Cancer Institute, 2009.
11. Merrill RM,. Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States. Ann Epidemiol 2006; 16: 880-7. (Pubitemid 44855648)
12. Sherman ME, Carreon JD, Lacey JV, Jr, Devesa SS,. Impact of hysterectomy on endometrial carcinoma rates in the United States. J Natl Cancer Inst 2005; 97: 1700-2. (Pubitemid 41672237)
13. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, II, Alberts D, Curtin J,. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006; 106: 812-19. (Pubitemid 43238448)
14. Lacey JV, Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, Duggan MA, Glass AG, Richesson DA, Chatterjee N, Langholz B,. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol 2010; 28: 788-92.
15. Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, Jordan CD, Epplein M, Swisher E, Upson K, Ehrlich KJ, Weiss NS,. Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy. Obstet Gynecol 2010; 116: 365-73.
16. Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, Allison K, Voigt LF, Weiss NS,. Incidence of endometrial hyperplasia. Am J Obstet Gynecol 2009; 200: 678 e1-e6.
17. Whiteman MK, Hillis SD, Jamieson DJ, Morrow B, Podgornik MN, Brett KM, Marchbanks PA,. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008; 198: 34 e1-e7.
18. Merrill RM,. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit 2008; 14: CR24-CR31.
19. Jacobson GF, Shaber RE, Armstrong MA, Hung YY,. Hysterectomy rates for benign indications. Obstet Gynecol 2006; 107: 1278-83. (Pubitemid 44336891)
20. Wagner EH, Greene SM, Hart G, Field TS, Fletcher S, Geiger AM, Herrinton LJ, Hornbrook MC, Johnson CC, Mouchawar J, Rolnick SJ, Stevens VJ, et al. Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr 2005;35: 3-11.
21. Current Population Survey (CPS) Table Creator. For the Annual Social and Economic Supplement, 2010. Available at http://www.census.gov/hhes/www/cpstc/ cps-table-creator.html. Accessed on December 22, 2011.
22. Glass AG, Lacey JV, Jr, Carreon JD, Hoover RN,. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007; 99: 1152-61. (Pubitemid 47233065)
23. (CDC) CfDCaP. Behavioral Risk Factor Surveillance System Survey Data. In: Services USDoHaH, ed., vol. 1991-2002: Centers for Disease Control and Prevention. Available at http://www.cdc.gov/brfss/.
24. Guide to Data on the Older Population in Census 2000 Summary Files 1-3. March 2002. Available at: http://www.census.gov/hhes/www/cpstc/cps-table- creator.html U.S. Census Bureau, Population Division.
25. Devesa SS,. Cancer patterns among women in the United States. Semin Oncol Nurs 1995; 11: 78-87.
26. Kim HJ, Fay MP, Feuer EJ, Midthune DN,. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-51. (Pubitemid 30070608)
27. Lyon JL, Gardner JW,. The rising frequency of hysterectomy: its effect on uterine cancer rates. Am J Epidemiol 1977; 105: 439-43. (Pubitemid 8112064)
28. Dicker RC, Scally MJ, Greenspan JR, Layde PM, Ory HW, Maze JM, Smith JC,. Hysterectomy among women of reproductive age: trends in the United States, 1970-1978. JAMA 1982; 248: 323-7. (Pubitemid 12070766)
29. Brett KM, Madans JH,. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997; 145: 536-45. (Pubitemid 27111222)
30. Trial TWGftP. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1996; 275: 370-5.
31. Hersh AL, Stefanick ML, Stafford RS,. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 2004; 291: 47-53. (Pubitemid 38040534)
32. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1996; 275: 370-5.
33. Farquhar CM, Steiner CA,. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 2002; 99: 229-34. (Pubitemid 34113994)
34. Silverberg SG,. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 2000; 13: 309-27. (Pubitemid 30207515)
35. Lacey JV, Jr, Ioffe OB, Ronnett BM, Rush BB, Richesson DA, Chatterjee N, Langholz B, Glass AG, Sherman ME,. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br J Cancer 2008; 98: 45-53.
36. Bilgin T, Ozuysal S, Ozan H, Atakan T,. Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia. J Obstet Gynaecol Res 2004; 30: 205-9. (Pubitemid 38855824)
37. Shutter J, Wright TC, Jr,. Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia. Int J Gynecol Pathol 2005; 24: 313-18. (Pubitemid 41368281)
38. Valenzuela P, Sanz JM, Keller J,. Atypical endometrial hyperplasia: grounds for possible misdiagnosis of endometrial adenocarcinoma. Gynecol Obstet Invest 2003; 56: 163-7. (Pubitemid 37346765)
39. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE,. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009; 114: 121-7.
40. U.S. Obesity Trends. Available at: http://www.cdc.gov/obesity/data/ trends.html. Division of Nutrition, Physical Activity, and Obesity; National Center for Chronic Disease Prevention and Health Program; Centers for Disease Control and Prevention.
41. Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, Weiss NS,. Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am J Epidemiol 2008; 168: 563-70; discussion 71-6.
42. Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, Wilcox LS,. Hysterectomy surveillanceâ€"United States, 1980-1993. MMWR CDC Surveill Summ 1997; 46: 1-15.